English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04863248 /

G1T28-210

A Phase 2 Randomized, Double-Blind, Clinical Trial Of Trilaciclib Versus Placebo In Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Treated With Docetaxel In The 2nd/3rd Line Setting (PRESERVE 4)

DISEASE GROUP:
Lung Cancer Clinical Trials
current phase:
II
STUDY STATUS:
Accepting Patients
Location:
Little Silver, NJ
For More information: